Xintrum Pharmaceuticals, Ltd. was established in 2011.

　　Xintrum Pharmaceuticals, Ltd. is a biomedical company focusing on R & D, integrating new drug R & D, clinical testing and manufacturing.

　　Xintrum Pharmaceuticals   technology core team is composed of overseas returnees and domestic pharmaceutical R & D elites. It is committed to the R & D of class I new drugs, biological analogues and vaccines of genetic engineering biological drugs, including gene cloning, cell line construction, protein structure and biochemical analysis, cell culture and purification process optimization, and large-scale industrial production. Treatment areas include cancer, cardiovascular and cerebrovascular diseases, central and peripheral nervous system diseases, and autoimmune diseases. At the same time, Xintrum Pharmaceuticals  is also committed to the research and development of clinical diagnostic reagents to adapt to the trend of personalized treatment in the pharmaceutical industry.

　　As a biopharmaceutical company integrating modern high-end medicine and diagnostic technology, the development strategy of Xintrum Pharmaceuticals, Ltd.  is to become a provider of systematic medical solutions in the 21st century; Help doctors to provide patients with prevention, diagnosis, treatment, monitoring of one-stop system of treatment. Based on health care and innovation, we are committed to growing into a dynamic, vigorous and international pharmaceutical enterprise.